Showing results (21-30 of 84) with videos related to
Sort By:
Pageof 9
The Journal of Clinical Investigation|December 1, 1984
Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjectsC J Packard, A Munro, A R Lorimer, et al.Journal of Human Hypertension|August 15, 1998
Differences between amlodipine and lisinopril in control of clinic and twenty-four hour ambulatory blood pressuresA R Lorimer, D Lyons, G Fowler, et al.Clinical Science and Molecular Medicine. Supplement|December 1, 1978
Benzothiadazine diuretics and death from myocardial infarction in hypertensionJ V Jones, F G Dunn, R Fife, et al.Journal of Lipid Research|September 1, 1986
Effects of bezafibrate on apolipoprotein B metabolism in type III hyperlipoproteinemic subjectsC J Packard, R J Clegg, M H Dominiczak, et al.Postgraduate Medical Journal|January 1, 1975
The prevalence of hyperlipoproteinaemia in vascular diseaseT D Lawrie, A R Lorimer, D Ballantyne, et al.Artery|January 1, 1980
Combined drug therapy for familial hypercholesterolemiaC J Packard, J M Stewart, H G Morgan, et al.Postgraduate Medical Journal|January 1, 1981
Non-invasive cardiovascular assessment of indapamide in patients with essential hypertensionF G Dunn, W S Hillis, A Tweddel, et al.Atherosclerosis|September 1, 1982
Effects of bezafibrate on receptor-mediated and receptor-independent low density lipoprotein catabolism in type II hyperlipoproteinaemic subjectsJ M Stewart, C J Packard, A R Lorimer, et al.British Journal of Pharmacology|May 1, 1974
The effects of a new beta-adrenoceptor blocking compound, tolamolol, on haemo-dynamics and myocardial function in manW S Hillis, I Hutton, T D Lawrie, et al.Arteriosclerosis (Dallas, Tex.)|March 1, 1985
Fenofibrate reduces low density lipoprotein catabolism in hypertriglyceridemic subjectsJ Shepherd, M J Caslake, A R Lorimer, et al.Pageof 9